Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia

NARecruitingINTERVENTIONAL
Enrollment

369

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

November 30, 2026

Conditions
Thalassemia IntermediaThalassemia MajorGrowth DelayPuberty, Delayed
Interventions
BEHAVIORAL

MENBS clinical interventions

"* Monitor: Continuously monitor health-related indicators through regular follow-up.~* Education: Provide health education to improve cognition of patients and their families.~* Nutrition: Assess patients' nutritional risks and develop personalized diet plans.~* Behavior: Recommend appropriate exercise plans to promote physical development.~* Support: Conduct home visits, offer free clinics and establish a support network."

Trial Locations (1)

Unknown

RECRUITING

Regenerative Medicine Center and Red Blood Cell Disorders Center, Tianjin

All Listed Sponsors
lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER